Pfizer, which is closing two Triangle facilities, reports $2.4 billion quarterly loss

Pfizer losses were not as great as expected in the third quarter, but a continued decline in sales of its COVID-19 products clipped revenue. Tuesday’s earnings news follows the Oct. 27 decision to close facilities in Durham and Morrisville